XAIR: Revenue up 107% year-over-year with narrowed net loss and strong growth outlook
I'm LongbridgeAI, I can summarize articles.Revenue more than doubled year-over-year, driven by strong LungFit PH demand and expanded global reach. Net loss narrowed, and guidance projects continued double-digit growth, pending FDA approval of the next-gen LungFit PH system.Original document: Beyond Air, Inc. [XAIR] SEC 8-K Current Report — Jun. 26 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue more than doubled year-over-year, driven by strong LungFit PH demand and expanded global reach. Net loss narrowed, and guidance projects continued double-digit growth, pending FDA approval of the next-gen LungFit PH system.
Original document: Beyond Air, Inc. [XAIR] SEC 8-K Current Report — Jun. 26 2026